These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


439 related items for PubMed ID: 17203844

  • 1. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
    Neĭman KP, Rumiantsev VG.
    Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C.
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [Abstract] [Full Text] [Related]

  • 3. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC, Hanauer SB.
    Rev Gastroenterol Disord; 2004 Nov; 4(3):104-17. PubMed ID: 15359211
    [Abstract] [Full Text] [Related]

  • 4. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B.
    Tidsskr Nor Laegeforen; 2003 Sep 25; 123(18):2565-7. PubMed ID: 14714043
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE, Hanauer SB.
    Gastroenterol Clin North Am; 2004 Jun 25; 33(2):303-17, ix-x. PubMed ID: 15177540
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M, Moum B.
    Tidsskr Nor Laegeforen; 2007 Oct 18; 127(20):2696-9. PubMed ID: 17952155
    [Abstract] [Full Text] [Related]

  • 13. Education and imaging. Gastrointestinal: gastric Crohn's disease.
    Tseng TC, Chang YT, Wong JM.
    J Gastroenterol Hepatol; 2007 Oct 18; 22(10):1690. PubMed ID: 17845696
    [No Abstract] [Full Text] [Related]

  • 14. [Inflammatory diseases of the intestines].
    Felley C, Guyot J, Hess J, Mottet C, Delarive J, Michetti P.
    Rev Med Suisse; 2006 Jan 18; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
    [Abstract] [Full Text] [Related]

  • 15. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May 07; 151(19):38-9. PubMed ID: 19827443
    [No Abstract] [Full Text] [Related]

  • 16. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE, Helmstädter V.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Ulcerative and granulomatous colitis].
    Bosseckert H.
    Z Gesamte Inn Med; 1981 Jan 01; 36(1):suppl 207-8. PubMed ID: 6111867
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B, Martínez-Cuesta MA, Calatayud S, Hinojosa J, Esplugues JV.
    Gastroenterol Hepatol; 1997 Jan 01; 20(6):322-34. PubMed ID: 9296850
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.